These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 2970367

  • 1. A study of adrenal corticol function and its reserve activity in long-acting injectable contraceptive users.
    Amatayakul K, Petpoo W, Ratanawananukul N, Tanthayaphinant O, Tovanabutra S, Suriyanon V.
    Contraception; 1988 May; 37(5):483-92. PubMed ID: 2970367
    [Abstract] [Full Text] [Related]

  • 2. Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile.
    Fahmy K, Abdel-Razik M, Shaaraway M, al-Kholy G, Saad S, Wagdi A, al-Azzony M.
    Contraception; 1991 Oct; 44(4):419-30. PubMed ID: 1836754
    [Abstract] [Full Text] [Related]

  • 3. The effects of long-acting injectable contraceptives on carbohydrate metabolism.
    Amatayakul K, Suriyanon V.
    Int J Gynaecol Obstet; 1985 Oct; 23(5):361-8. PubMed ID: 2866986
    [Abstract] [Full Text] [Related]

  • 4. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
    [Abstract] [Full Text] [Related]

  • 5. Long-acting hormonal contraceptives for women.
    Garza-Flores J, Hall PE, Perez-Palacios G.
    J Steroid Biochem Mol Biol; 1991 Jan; 40(4-6):697-704. PubMed ID: 1958567
    [Abstract] [Full Text] [Related]

  • 6. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report.
    Contraception; 1983 Jul; 28(1):1-20. PubMed ID: 6226488
    [Abstract] [Full Text] [Related]

  • 7. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
    Enk L, Landgren BM, Lindberg UB, Silfverstolpe G, Crona N.
    Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
    [Abstract] [Full Text] [Related]

  • 8. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
    Swenson I, Khan AR, Jahan FA.
    Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
    [Abstract] [Full Text] [Related]

  • 9. Acceptability of injectable contraceptives in Assiut, Egypt.
    Salem HT, Salah M, Aly MY, Thabet AI, Shaaban MM, Fathalla MF.
    Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583
    [Abstract] [Full Text] [Related]

  • 10. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
    Sang GW.
    Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
    [Abstract] [Full Text] [Related]

  • 11. Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters.
    Haiba NA, el-Habashy MA, Said SA, Darwish EA, Abdel-Sayed WS, Nayel SE.
    Contraception; 1989 Jun; 39(6):619-32. PubMed ID: 2666019
    [Abstract] [Full Text] [Related]

  • 12. Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-acting Systemic Agents for the Regulation of Fertility.
    Gray RH, Parker RA, Diethelm P.
    Br J Obstet Gynaecol; 1981 Mar; 88(3):317-21. PubMed ID: 7008825
    [Abstract] [Full Text] [Related]

  • 13. Serium protein-bound carbohydrate and seromucoid levels during long-acting progestational contraceptive therapy.
    Saleh FM.
    Contraception; 1977 Oct; 16(4):399-407. PubMed ID: 923250
    [Abstract] [Full Text] [Related]

  • 14. A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
    Bassol S, Hernandez C, Nava MP, Trujillo AM, Luz de la Cruz D.
    Contraception; 1995 May; 51(5):307-11. PubMed ID: 7628206
    [Abstract] [Full Text] [Related]

  • 15. Estrogen-progestogen once-a-month injectable contraceptives and serum prolactin.
    Garza-Flores J, Alba VM, Cravioto MC, Hernandez L, Perez-Palacios G, Alvarado G, Rivera R, Recio R, Bassol S.
    Contraception; 1989 May; 39(5):519-29. PubMed ID: 2524362
    [Abstract] [Full Text] [Related]

  • 16. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
    Adlercreutz H, Pulkkinen MO, Hämäläinen EK, Korpela JT.
    J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
    [Abstract] [Full Text] [Related]

  • 17. Return of fertility in women discontinuing injectable contraceptives.
    Fotherby K, Howard G.
    J Obstet Gynaecol (Lahore); 1986 Apr; 6 Suppl 2():S110-5. PubMed ID: 12315276
    [Abstract] [Full Text] [Related]

  • 18. Pituitary response to LHRH in long-term users of injectable contraceptives.
    Ismail AA, el-Faras A, Rocca M, el-Sibai FA, Toppozada M.
    Contraception; 1987 May; 35(5):487-95. PubMed ID: 2957167
    [Abstract] [Full Text] [Related]

  • 19. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: noresthisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects.
    Contraception; 1978 May; 17(5):395-406. PubMed ID: 657807
    [Abstract] [Full Text] [Related]

  • 20. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
    Fraser IS.
    Contraception; 1983 Oct; 28(4):385-97. PubMed ID: 6230212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.